Literature DB >> 17717204

Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation.

Patrick O Mitchell1, David M Guidot.   

Abstract

RATIONALE: Obliterative bronchiolitis (OB) after lung transplantation is triggered by alloimmunity, but is ultimately mediated by transforming growth factor (TGF)-beta(1)-dependent airway fibrosis.
OBJECTIVES: Chronic alcohol use increases TGF-beta(1) expression and renders the lung susceptible to injury. Therefore, we hypothesized that donor alcohol abuse could prime the lung allograft for OB, as many organ donors have a history of alcohol abuse.
METHODS: Tracheas from control and alcohol-fed rats (8 wk) were heterotopically transplanted into recipients with varying degrees of alloimmune mismatch and analyzed for obliterative airway disease severity on Postoperative Day 21.
MEASUREMENTS AND MAIN RESULTS: Although donor alcohol ingestion did not increase the number of antigen-presenting cells or infiltrating lymphocytes, it nevertheless increased allograft lumenal collagen content fourfold compared with allografts from control donors. In parallel, alcohol increased TGF-beta(1) and alpha-smooth muscle actin expression in allografts. Alcohol amplified airway disease even in isografts with minor alloimmune mismatches. In contrast, it did not cause any airway disease in isografts in a pure isogenic background, suggesting that a minimal alloimmune response is necessary to trigger alcohol-induced airway fibrosis.
CONCLUSIONS: Although alloimmune inflammation is required to initiate airway disease, alcohol primes the allograft for greater TGF-beta(1) expression, myofibroblast transdifferentiation, and fibrosis than by alloimmune inflammation alone. This has serious clinical implications, as many lung donors have underlying alcohol abuse that may prime the allograft recipient for subsequent OB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717204      PMCID: PMC2176096          DOI: 10.1164/rccm.200702-255OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

1.  Bronchoalveolar lavage macrophage and lymphocyte phenotypes in lung transplant recipients.

Authors:  C Ward; H Whitford; G Snell; H Bao; L Zheng; D Reid; T J Williams; E H Walters
Journal:  J Heart Lung Transplant       Date:  2001-10       Impact factor: 10.247

2.  The role of respiratory epithelium in a rat model of obliterative airway disease.

Authors:  B F Adams; T Brazelton; G J Berry; R E Morris
Journal:  Transplantation       Date:  2000-02-27       Impact factor: 4.939

3.  Myofibroblast transdifferentiation in obliterative bronchiolitis: tgf-beta signaling through smad3-dependent and -independent pathways.

Authors:  A M Ramirez; Z Shen; J D Ritzenthaler; J Roman
Journal:  Am J Transplant       Date:  2006-06-22       Impact factor: 8.086

4.  The effects of chronic alcohol abuse on pulmonary glutathione homeostasis.

Authors:  M Moss; D M Guidot; M Wong-Lambertina; T Ten Hoor; R L Perez; L A Brown
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

5.  Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation.

Authors:  J Scholma; D J Slebos; H M Boezen; J W van den Berg; W van der Bij; W J de Boer; G H Koëter; W Timens; H F Kauffman; D S Postma
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

Review 6.  Risk factors for bronchiolitis obliterans: a systematic review of recent publications.

Authors:  Linda D Sharples; Keith McNeil; Susan Stewart; John Wallwork
Journal:  J Heart Lung Transplant       Date:  2002-02       Impact factor: 10.247

7.  Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration.

Authors:  Martine Reynaud-Gaubert; Valerie Marin; Xavier Thirion; Catherine Farnarier; Pascal Thomas; Monique Badier; Pierre Bongrand; Roger Giudicelli; Pierre Fuentes
Journal:  J Heart Lung Transplant       Date:  2002-07       Impact factor: 10.247

8.  Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?

Authors:  Christopher H Jackson; Linda D Sharples; Keith McNeil; Susan Stewart; John Wallwork
Journal:  J Heart Lung Transplant       Date:  2002-06       Impact factor: 10.247

9.  Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.

Authors:  Timothy W Schacker; Phuong L Nguyen; Gregory J Beilman; Steven Wolinsky; Matthew Larson; Cavan Reilly; Ashley T Haase
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

10.  Glutathione replacement preserves the functional surfactant phospholipid pool size and decreases sepsis-mediated lung dysfunction in ethanol-fed rats.

Authors:  Alvaro Velasquez; Rabih I Bechara; James F Lewis; Jaret Malloy; Lynda McCaig; Lou Ann S Brown; David M Guidot
Journal:  Alcohol Clin Exp Res       Date:  2002-08       Impact factor: 3.455

View more
  4 in total

1.  Chronic alcohol ingestion and predisposition to lung "cirrhosis".

Authors:  Jesse Roman
Journal:  Alcohol Clin Exp Res       Date:  2014-01-15       Impact factor: 3.455

2.  The relative balance of GM-CSF and TGF-β1 regulates lung epithelial barrier function.

Authors:  Christian E Overgaard; Barbara Schlingmann; StevenClaude Dorsainvil White; Christina Ward; Xian Fan; Snehasikta Swarnakar; Lou Ann S Brown; David M Guidot; Michael Koval
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-17       Impact factor: 5.464

3.  Alcohol primes the airway for increased interleukin-13 signaling.

Authors:  Patrick O Mitchell; J Spencer Jensen; Jeffrey D Ritzenthaler; Jesse Roman; Andres Pelaez; David M Guidot
Journal:  Alcohol Clin Exp Res       Date:  2008-12-19       Impact factor: 3.455

4.  The role of donor chronic alcohol abuse in the development of primary graft dysfunction in lung transplant recipients.

Authors:  Andres Pelaez; Patrick O Mitchell; Nimesh S Shah; Seth D Force; Lisa Elon; Lou Ann S Brown; David M Guidot
Journal:  Am J Med Sci       Date:  2015-02       Impact factor: 2.378

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.